SCHEMBL6779846

SCHEMBL6779846

OCC(CCCc1ccccc1)CCCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.50
HDAC3 O15379 2/20 0.47
HDAC4 P56524 2/20 0.47
HDAC1 Q13547 2/20 0.47
HDAC7 Q8WUI4 2/20 0.47
HDAC2 Q92769 2/20 0.47
HDAC10 Q969S8 2/20 0.47
HDAC11 Q96DB2 2/20 0.47
HDAC8 Q9BY41 2/20 0.47
HDAC6 Q9UBN7 2/20 0.47
HDAC9 Q9UKV0 2/20 0.47
HDAC5 Q9UQL6 2/20 0.47
MAPK1 P28482 1/20 0.47
ADRA1A P35348 1/20 0.47
SLC6A3 Q01959 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
GRIK1 P39086 1/20 0.46
SIGMAR1 Q99720 1/20 0.45
MAOA P21397 1/20 0.45
MAPT P10636 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10712129 0.96 TDP1 (0.50) TDP1HDAC3HDAC4HDAC1HDAC7
SCHEMBL19258910 0.92 TDP1 (0.46) TDP1HDAC3HDAC4HDAC1HDAC7
SCHEMBL112814 0.91 SIGMAR1 (0.46) TDP1ADRA1ASLC6A3GRIK1SIGMAR1
SCHEMBL11693551 0.90 TRPA1 (0.46) TDP1HDAC3HDAC4HDAC1HDAC7
SCHEMBL6989076 0.88 ALDH1A1 (0.50) TDP1HDAC3HDAC4HDAC1HDAC7
SCHEMBL19285755 0.86 TDP1 (0.54) TDP1SMN1; SMN2HTR2A
SCHEMBL11274710 0.86 TDP1 (0.44) TDP1SMN1; SMN2
SCHEMBL9670504 0.84 CA2 (0.37) SLC6A3
SCHEMBL19824586 0.83 FDFT1 (0.53) HDAC1HDAC2KCNH2
SCHEMBL4595228 0.82 TDP1 (0.54) TDP1SMN1; SMN2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6818643-B1 3,9-DIAZABICYCLO(3.3.1)NONAN-2-ONE DERIVATIVES; PEPTIDYL-PROLYL ISOMERASE (PPIASE OR ROTAMASE) INHIBITORS; NEUROPROTECTIVE AGENTS BRISTOL-MYERS SQUIBB COMPANY 2004-11-16 US disclosed
WO-2001042245-A1 NEUROTROPHIC BICYCLIC DIAMIDES BRISTOL-MYERS SQUIBB COMPANY (US) 2001-06-14 WO disclosed